BioWorld — Gone fishing: Blackfynn's data platform likely lure for partners in neurology

Philadelphia-based Blackfynn has lately hit several milestones in the company's growth, including a $1.4 million contract with the Defense Advanced Research Projects Agency (DARPA), deployment of the Blackfynn Data Platform within the Children's Brain Tumor Tissue Consortium (CBTTC) led by Children's Hospital of Philadelphia (CHOP), plus newly established collaborations with the Mayo Clinic, Medtronic, the University of Pennsylvania, and the Epilepsy Study Consortium.